PublicationsA potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

Support our work

A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

Research group Verhaagen

Publication year 2010

Published in Biotechnology Letters

Authors A. Zalmbumbide, S. Weening, S.J. Cramer, M.J. Rabelink, J. Verhaagen, R.C. Hoeben

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.